ClinConnect ClinConnect Logo
Search / Trial NCT04782284

Comprehensive Swallowing Rehabilitation in Patients With MSA

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Mar 1, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Multiple System Atrophy Dysphagia Swallowing Rehabilitation Videofluoroscopic Swallowing Study

ClinConnect Summary

This clinical trial is looking at how a special swallowing therapy can help people with Multiple System Atrophy (MSA), a condition that affects movement and can cause difficulties with swallowing. The study aims to see if this comprehensive rehabilitation program can improve swallowing function in patients diagnosed with MSA.

To be eligible for this study, participants need to be at least 19 years old and have a confirmed diagnosis of MSA along with swallowing difficulties, known as dysphagia. They must also have had a specific swallowing test that shows a certain level of swallowing issues. Participants will be able to receive tailored therapy to help improve their swallowing abilities. It’s important to note that people with significant cognitive challenges or other serious health conditions that might interfere with their ability to participate are not eligible for the trial. This study is currently looking for volunteers, so if you or someone you know fits the criteria, it could be a valuable opportunity for support.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \>19 years
  • Clinically diagnosed with MSA according to the guidelines of the 2nd consensus of the Gilman criteria
  • Clinically diagnosed to have dysphagia by a physiatrist
  • Two or more points on the Penetration-aspiration scale (PAS) from the Videofluoroscopic swallowing study (VFSS) conducted within 3 months
  • Exclusion Criteria:
  • Moderate to severe cognitive dysfunction with Mini-mental State Examination score \< 19
  • Comorbidities or structural abnormalities that may affect swallowing function
  • Other comorbidities that make it difficult to participate in the study

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

Seoul, Seoul Teugbyeolsi, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Han Gil Seo, MD, PhD

Principal Investigator

Seoul National University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials